vimarsana.com

Page 2 - ஆரோக்கியம் அமைச்சகம் கூட்டு செயலாளர் லாவ் அகர்வால் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covaxin s phase three data likely to be published in a week, says Centre

India reports 92,596 new COVID-19 cases

Coronavirus | India dismisses New York Times report on COVID-19 death toll as completely baseless

Updated: May 27, 2021 20:46 IST The report estimated 600,000 deaths due to the infection in the country in a conservative scenario, 1.6 million estimated deaths in a more likely scenario and 4.2 million estimated deaths in a worse scenario. Share Article AAA The body of Pramila Devi, 36, who died from complications related to COVID-19, is seen before her cremation, on the banks of the Ganga in Pauri Garhwal, Uttarakhand on May 24, 2021.   | Photo Credit: Reuters The report estimated 600,000 deaths due to the infection in the country in a conservative scenario, 1.6 million estimated deaths in a more likely scenario and 4.2 million estimated deaths in a worse scenario.

Moderna to launch single-dose COVID-19 vaccine in India in 2022, Pfizer ready to offer 5 crore doses this year

Meanwhile, Pfizer is ready to offer 5 crore doses this year New Delhi: Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including indemnification, sources said on Tuesday. While Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021, there are limited prospects of Johnson & Johnson exporting its jabs from the US to other countries in the near future, the sources privy to discussions added.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.